Mr. Frank Holler brings a wide-ranging experience to his role as PROOF Centre’s Chairman of the Board. An active investor and successful entrepreneur, Mr. Holler is currently the CEO and partner of Lions Capital Corp., and the fund manager for BC Advantage Funds and the Lions Funds. He previously served as President & CEO of Xenon Pharmaceuticals Inc., a private genomics-based drug development company from 1999 to 2003; as President & CEO of ID Biomedical Corporation, a vaccine development company sold to GlaxoSmithKline plc in 2005 from 1991 to 1998; and as the founding director of Angiotech Pharmaceuticals, a TSX/ NASDAQ listed medical device company from 1992 to 1997.
Prior to working in biotechnology and healthcare, Mr. Holler was an Investment Banker with Merrill Lynch Canada and Wood Gundy Inc. (now CIBC World Markets).
Mr. Holler presently serves on the board of directors of Protox Therapeutics Inc. (Chairman), Allon Therapeutics Inc., Aquinox Pharmaceuticals Inc., Genome British Columbia, Providence Healthcare and Xenon Pharmaceuticals Inc. He was previously Director of the British Columbia Biotechnology Association from 1992 to 1998. In 2003, Mr. Holler received the BC Biotech Award for Vision and Leadership.
Mr. Holler holds a Masters of Business Administration degree and Bachelor of Arts (Economics) degree from the University of British Columbia.
